Get started
Author

Hiroshi Ishiba

Observed names: HIROSHI ISHIBA, Ishiba, Hiroshi
ORCID: 0000-0002-1516-5938
Observed ORCID: 0000-0002-1516-5938
OpenAlex ID: A5030544871
The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study
2018 · for the Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD), Hiroshi Ishiba, et al. · Journal of Gastroenterology · 137
Effect of 12‐week dulaglutide therapy in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease and type 2 diabetes mellitus
2016 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 96
Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non‐alcoholic fatty liver disease and type 2 diabetes mellitus
2016 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 91
Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease
2014 · Yoshio Sumida, Yoshikazu Yonei, et al. · Hepatology Research · 89
Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease
2015 · Yoshio Sumida, Kazuyuki Kanemasa, et al. · Journal of Gastroenterology · 86
Development of hepatocellular carcinoma in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression
2016 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 85
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma
2019 · AYA TAKAHASHI, MICHIHISA MORIGUCHI, et al. · Anticancer Research · 71
Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice
2021 · Kota Yano, Kanji Yamaguchi, et al. · Laboratory Investigation · 67
Serum alanine aminotransferase predicts the histological course of non‐alcoholic steatohepatitis in J apanese patients
2014 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 61
Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes
2020 · Hiroshi Ishiba, Yoshio Sumida, et al. · Hepatology Communications · 54
PDF
Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high‐fat diet fed mice
2014 · Kanji Yamaguchi, Takeshi Nishimura, et al. · Liver International · 47
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
2020 · Yoshio Sumida, Masashi Yoneda, et al. · Diagnostics · 36
PDF
Hepatic nucleotide binding oligomerization domain‐like receptors pyrin domain‐containing 3 inflammasomes are associated with the histologic severity of non‐alcoholic fatty liver disease
2017 · Hironori Mitsuyoshi, Kohichiroh Yasui, et al. · Hepatology Research · 33
Predictors of malignancies and overall mortality in J apanese patients with biopsy‐proven non‐alcoholic fatty liver disease
2014 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 30
Association of coronary artery calcification with liver fibrosis in Japanese patients with non‐alcoholic fatty liver disease
2016 · Hiroshi Ishiba, Yoshio Sumida, et al. · Hepatology Research · 29
Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease
2017 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 28
PDF
Liver stiffness measurement to platelet ratio index predicts the stage of liver fibrosis in non‐alcoholic fatty liver disease
2016 · Akira Okajima, Yoshio Sumida, et al. · Hepatology Research · 26
Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis
2020 · Aya Takahashi, Michihisa Moriguchi, et al. · Cancers · 25
PDF
Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction
2024 · Kento Takeuchi, Kanji Yamaguchi, et al. · Scientific Reports · 24
PDF
PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat
2020 · Shinya Okishio, Kanji Yamaguchi, et al. · Scientific Reports · 19
PDF
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction–associated steatotic liver disease
2024 · Hiroshi Ishiba, Hideki Fujii, et al. · Hepatology Communications · 13
Noninvasive tests predict liver‐related events and mortality in patients with nonalcoholic fatty liver disease: sub‐analysis of the CLIONE‐Asia study
2023 · Hiroshi Ishiba, Yoshio Sumida, et al. · Journal of Gastroenterology and Hepatology · 7
Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice
2019 · Hiroyoshi Taketani, Taichiro Nishikawa, et al. · Diabetes Metabolic Syndrome and Obesity · 7
PDF
Correction to: The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study
2018 · for the Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD), Hiroshi Ishiba, et al. · Journal of Gastroenterology · 5
PDF
Drug‐induced liver injury in a chronic hepatitis C patient treated by peginterferon, ribavirin and simeprevir
2015 · Akira Okajima, Kanji Yamaguchi, et al. · Hepatology Research · 5
PDF
Works count: 31
Citation count: 1,178
H-index: 19
I10-index: 21
Year
Topic
Type